RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Fresenius Medical Care Stock

Fresenius Medical Care Revenue 2024

Fresenius Medical Care Revenue

19.5 B EUR

Ticker

FME.DE

ISIN

DE0005785802

WKN

578580

In 2024, Fresenius Medical Care's sales reached 19.5 B EUR, a 0.24% difference from the 19.45 B EUR sales recorded in the previous year.

The Fresenius Medical Care Revenue history

YEARREVENUE (undefined EUR)GROSS MARGIN (%)
2030e26.1718,82
2029e23.6820,80
2028e23.520,96
2027e22.9321,48
2026e20.8923,57
2025e20.1724,42
2024e19.525,26
202319.4525,32
202219.425,23
202117.6227,09
202017.8631,01
201917.4830,87
201816.5531,15
201717.7833,84
201616.5733,89
201515.4533,50
201412.1432,85
201311.2233,71
201210.9634,65
20119.1935,38
20109.0934,34
20098.0734,11
20087.2334,32
20077.1334,62
20066.7733,86
20055.4534,44
20045.0133,49

Fresenius Medical Care Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Fresenius Medical Care, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Fresenius Medical Care from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Fresenius Medical Care’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Fresenius Medical Care. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Fresenius Medical Care’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Fresenius Medical Care’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Fresenius Medical Care’s growth potential.

Fresenius Medical Care Revenue, EBIT and net profit per share

DateFresenius Medical Care RevenueFresenius Medical Care EBITFresenius Medical Care Net Income
2030e26.17 B undefined2.7 B undefined0 undefined
2029e23.68 B undefined2.6 B undefined1.72 B undefined
2028e23.5 B undefined2.76 B undefined1.53 B undefined
2027e22.93 B undefined2.68 B undefined1.48 B undefined
2026e20.89 B undefined2.28 B undefined1.13 B undefined
2025e20.17 B undefined2.05 B undefined1.01 B undefined
2024e19.5 B undefined1.75 B undefined819.17 M undefined
202319.45 B undefined1.28 B undefined499 M undefined
202219.4 B undefined1.29 B undefined673.41 M undefined
202117.62 B undefined1.78 B undefined969.31 M undefined
202017.86 B undefined2.24 B undefined1.16 B undefined
201917.48 B undefined2.29 B undefined1.2 B undefined
201816.55 B undefined2.31 B undefined1.98 B undefined
201717.78 B undefined2.54 B undefined1.28 B undefined
201616.57 B undefined2.35 B undefined1.14 B undefined
201515.45 B undefined2.1 B undefined954.95 M undefined
201412.14 B undefined1.67 B undefined781.34 M undefined
201311.22 B undefined1.66 B undefined811 M undefined
201210.96 B undefined1.68 B undefined920 M undefined
20119.19 B undefined1.48 B undefined776 M undefined
20109.09 B undefined1.45 B undefined742 M undefined
20098.07 B undefined1.26 B undefined636 M undefined
20087.23 B undefined1.15 B undefined557 M undefined
20077.13 B undefined1.17 B undefined531 M undefined
20066.77 B undefined1.02 B undefined427 M undefined
20055.45 B undefined756 M undefined365 M undefined
20045.01 B undefined686 M undefined322 M undefined

Fresenius Medical Care stock margins

The Fresenius Medical Care margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Fresenius Medical Care. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Fresenius Medical Care.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Fresenius Medical Care's sales revenue. A higher gross margin percentage indicates that the Fresenius Medical Care retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Fresenius Medical Care's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Fresenius Medical Care's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Fresenius Medical Care's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Fresenius Medical Care. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Fresenius Medical Care's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Fresenius Medical Care Margin History

Fresenius Medical Care Gross marginFresenius Medical Care Profit marginFresenius Medical Care EBIT marginFresenius Medical Care Profit margin
2030e25.32 %10.33 %0 %
2029e25.32 %10.96 %7.28 %
2028e25.32 %11.75 %6.52 %
2027e25.32 %11.7 %6.45 %
2026e25.32 %10.9 %5.43 %
2025e25.32 %10.18 %4.99 %
2024e25.32 %8.95 %4.2 %
202325.32 %6.57 %2.57 %
202225.23 %6.63 %3.47 %
202127.09 %10.1 %5.5 %
202031.01 %12.55 %6.52 %
201930.87 %13.1 %6.86 %
201831.15 %13.97 %11.98 %
201733.84 %14.27 %7.2 %
201633.89 %14.19 %6.9 %
201533.5 %13.59 %6.18 %
201432.85 %13.73 %6.43 %
201333.71 %14.77 %7.23 %
201234.65 %15.35 %8.39 %
201135.38 %16.06 %8.44 %
201034.34 %15.95 %8.16 %
200934.11 %15.6 %7.89 %
200834.32 %15.92 %7.7 %
200734.62 %16.45 %7.45 %
200633.86 %15.04 %6.31 %
200534.44 %13.87 %6.7 %
200433.49 %13.68 %6.42 %

Fresenius Medical Care Aktienanalyse

What does Fresenius Medical Care do?

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius Medical Care revenue by segment

  • 70 % North America

  • 15 % EMEA

  • 11 % Asia-Pacific

  • 4 % Latin America

Revenue Details

Understanding Fresenius Medical Care's Sales Figures

The sales figures of Fresenius Medical Care originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fresenius Medical Care’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fresenius Medical Care's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fresenius Medical Care’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fresenius Medical Care stock

How much revenue did Fresenius Medical Care generate this year?

Fresenius Medical Care has achieved a revenue of 19.5 B EUR this year.

How much was the turnover of the company Fresenius Medical Care compared to the previous year?

The revenue of Fresenius Medical Care has increased by 0.24% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fresenius Medical Care?

The revenue of Fresenius Medical Care is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fresenius Medical Care measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fresenius Medical Care so important for investors?

The revenue of Fresenius Medical Care is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fresenius Medical Care pay?

Over the past 12 months, Fresenius Medical Care paid a dividend of 1.12 EUR . This corresponds to a dividend yield of about 2.75 %. For the coming 12 months, Fresenius Medical Care is expected to pay a dividend of 1.14 EUR.

What is the dividend yield of Fresenius Medical Care?

The current dividend yield of Fresenius Medical Care is 2.75 %.

When does Fresenius Medical Care pay dividends?

Fresenius Medical Care pays a quarterly dividend. This is distributed in the months of September, June, June, June.

How secure is the dividend of Fresenius Medical Care?

Fresenius Medical Care paid dividends every year for the past 33 years.

What is the dividend of Fresenius Medical Care?

For the upcoming 12 months, dividends amounting to 1.14 EUR are expected. This corresponds to a dividend yield of 2.8 %.

In which sector is Fresenius Medical Care located?

Fresenius Medical Care is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fresenius Medical Care kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fresenius Medical Care from 5/21/2024 amounting to 1.19 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.

When did Fresenius Medical Care pay the last dividend?

The last dividend was paid out on 5/21/2024.

What was the dividend of Fresenius Medical Care in the year 2023?

In the year 2023, Fresenius Medical Care distributed 1.35 EUR as dividends.

In which currency does Fresenius Medical Care pay out the dividend?

The dividends of Fresenius Medical Care are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Fresenius Medical Care stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank

Andere Kennzahlen von Fresenius Medical Care

Our stock analysis for Fresenius Medical Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius Medical Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.